Stancare (Ranbaxy Laboratories Ltd.)
- C07 - Betabloqueantes
- CASLOT tablet 12.5 mg
- CASLOT tablet 25 mg
- CASLOT tablet 3.125 mg
- CASLOT tablet 6.25 mg
- C08 - Bloqueantes del canal de calcio
- VAMLO tablet 10 mg
- VAMLO tablet 2.5 mg
- VAMLO tablet 5 mg
- G04 - Urológicos
- DUTAGEN capsule, soft 0.5 mg
- J01 - Antibacterianos para uso sistémico
- ENHANCIN BD dispersible tablet 200 mg+28.5 mg
- ENHANCIN BD powder for oral suspension 200 mg/5 ml+28.5 mg/5 ml
- ENHANCIN BD tablet 875 mg+125 mg
- ENHANCIN film-coated tablet 250 mg+125 mg
- ENHANCIN oral drops, solution 80 mg/ml+11.4 mg/ml
- ENHANCIN powder for oral suspension 400 mg/5 ml+57 mg/5 ml
- ENHANCIN powder for solution for injection 1 g+200 mg
- ENHANCIN powder for syrup 125 mg/5 ml+31.25 mg/5 ml
- ENHANCIN tablet 875 mg+125 mg
- ZANOCIN DS film-coated tablet 400 mg
- ZANOCIN OD prolonged-release tablet 400 mg
- ZANOCIN OD prolonged-release tablet 600 mg
- ZANOCIN OD prolonged-release tablet 800 mg
- ZANOCIN oral solution 100 mg/5 ml
- ZANOCIN oral solution 50 mg/5 ml
- ZANOCIN solution for infusion 200 mg/100 ml
- ZANOCIN tablet 100 mg
- ZANOCIN tablet 200 mg
- P01 - Antiprotozoarios
- ZANOCIN TZ film-coated tablet 600 mg+200 mg
- ZANOCIN TZH film-coated tablet 300 mg+200 mg
- S01 - Oftalmológicos
- ZANOCIN eye drops, solution 0.3%
- ZENFLOX eye drops, solution 0.3%